South & Central AmericaCancer Vaccines Market to Grow at a CAGR of 16.3% to reach US$ 627.49 Million from 2020 to 2027

South and Central America Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector Cancer Vaccines); Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines); Indication (Cervical Cancer, Prostate Cancer, Other Indications); End User (Pediatrics, Adults), and Country

Publication Month: Oct 2020 | Report Code: TIPRE00015134 | No. of Pages: 164 | Category: Pharmaceuticals | Status: Published
Covid

The South and Central America cancer vaccines market was valued at US$ 191.89 million in 2019 and is projected to reach US$ 627.49 million by 2027; it is expected to grow at a CAGR of 16.3% during the forecast period.

The growth of the South & Central America Cancer Vaccines market is mainly attributed to the growing prevalence of cancer andinitiatives taken by global health organization.

 

Cancer is one of the primary epidemic diseases, and the number of people with cancer has become over double the number in the past three decades. According to data of an article, RevistaBrasileira de Cancerologia 2018, during 2018-2019, there would be approximately 600,000 new cases of cancer.

 

Brazil Cancer Vaccines Market Revenue and Forecast to 2027 (US$ Million)

 

SOUTH & CENTRAL AMERICA CANCER VACCINES – MARKET SEGMENTATION

 

By Technology

  • Dendritic Cells Cancer Vaccines
  • Recombinant Cancer Vaccines
  • Antigen Cancer Vaccines
  • Whole Cell Cancer Vaccines
  • Viral Vector Cancer Vaccines

By Type

  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccine

By Indication

  • Cervical Cancer
  • Prostate Cancer
  • Other Indications

By End Use

  • Pediatrics
  • Adults

By Country

  • Brazil
  • Argentina
  • RoSCAM

CompanyProfiles

  • AstraZeneca
  • GlaxoSmithKline plc.
  • Aduro Biotech Inc
  • Pfizer Inc.
  • Sanofi
  • Bristol-Myers Squibb
  • Moderna, Inc.
  • OncBioMune Pharmaceuticals Inc.
  • MaxiVAX
  • Nouscom

 

1.           Introduction. 16

1.1         Scope of the Study. 16

1.2         The Insight Partners Research Report Guidance. 16

1.3         Market Segmentation. 18

1.3.1        Central and South America Cancer Vaccines Market – By Technology. 20

1.3.2        Central and South America Cancer Vaccines Market – By Type. 20

1.3.3        Central and South America Cancer Vaccines Market – By Indication. 20

1.3.4        Central and South America Cancer Vaccines Market– By End Use. 20

1.3.5        Central and South America Cancer Vaccines Market– By Region. 21

2.           Cancer Vaccines Market – Key Takeaways. 22

3.           Research Methodology. 27

3.1         Coverage. 29

3.2         Secondary Research. 29

3.3         Primary Research. 30

4.           Cancer Vaccines – Market Landscape. 31

4.1         Overview.. 31

4.2         PEST Analysis. 31

4.3         Expert Opinion. 32

5.           Central and South America Cancer Vaccines Market – Industry Dynamics. 33

5.1         Key Drivers. 33

5.1.1        Increase in Prevalence of Cancer Worldwide. 33

5.1.2        Initiatives Taken by Global Health Research Organizations and Key Players for Cancer Vaccines. 34

5.2         Key Market Restraints. 35

5.2.1        Less Number of Commercially Available Vaccines for Treatment of Cancer 35

5.2.2        Higher Cost of Cancer Vaccines. 35

5.3         Key Market Opportunities. 36

5.3.1        Increasing Government support in Emerged Countries. 36

5.4         Future Trends. 36

5.4.1        Growing Research and Development Activities. 36

5.5         Impact analysis. 38

6.           Cancer Vaccines Market – Regional Analysis. 39

6.1         Central and South America Cancer Vaccines Market Revenue Forecast And Analysis. 39

7.           Central and South America Cancer Vaccines Market Analysis – By Technology. 41

7.1         Overview.. 41

7.2         Cancer Vaccines Market Share, by Technology, 2019 and 2027 (%) 41

7.3         Dendritic Cells Cancer Vaccine. 43

7.3.1        Overview.. 43

7.3.2        Dendritic Cells Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 44

7.5         Recombinant Cancer Vaccines. 45

7.5.1        Overview.. 45

7.5.2        Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 46

7.6         Antigen Cancer Vaccines. 47

7.6.1        Overview.. 47

7.6.2        Antigen Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 48

7.7         Whole Cell Cancer Vaccines. 49

7.7.1        Overview.. 49

7.7.2        Whole Cell Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 50

7.8         Viral Vector Cancer Vaccines. 51

7.8.1        Overview.. 51

7.8.2        Viral Vector Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 52

8.           Cancer Vaccines Market Analysis – By Type. 53

8.1         Overview.. 53

8.2         Cancer Vaccines Market Revenue Share, by Type (2019 and 2027) 53

8.3         Preventive Cancer Vaccines. 55

8.3.1        Overview.. 55

8.3.2        Preventive Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 56

8.4         Therapeutic Cancer Vaccines. 57

8.4.1        Overview.. 57

8.4.2        Therapeutic Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 58

9.           Cancer Vaccines Market Analysis – By Indication. 59

9.1         Overview.. 59

9.2         Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027) 59

9.3         Cervical Cancer 61

9.3.1        Overview.. 61

9.3.2        Cervical Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 62

9.4         Prostate Cancer 63

9.4.1        Overview.. 63

9.4.2        Prostate Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 64

9.5         Other Indications. 65

9.5.1        Overview.. 65

9.5.2        Other Indications: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 66

10.        Cancer Vaccines Market Analysis – By End Use. 67

10.1      Overview.. 67

10.2      Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027) 67

10.3      Pediatrics. 68

10.3.1     Overview.. 68

10.3.2     Pediatrics: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 69

10.4      Adults. 70

10.4.1     Overview.. 70

10.4.2     Adults: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million) 70

11.        Cancer Vaccines Market – Geographic Analysis. 72

11.1      Central and South America: Cancer Vaccines Market 72

11.1.1     Overview.. 72

11.1.2     South and Central America: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 74

11.1.3     South and Central America Cancer Vaccines Market, by Type – Revenue and Forecast to 2027  (USD Million) 75

11.1.4     South and Central America Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027  (USD Million) 76

11.1.5     South and Central America Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million) 77

11.1.6     South and Central America Cancer Vaccines Market, by End User – Revenue and Forecast to 2027  (USD Million) 78

11.1.7     South and Central America: Cancer Vaccines Market, by Country, 2019 & 2027 (%) 78

11.1.8     Brazil: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 79

11.1.8.1       Brazil: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 79

11.1.8.2       Brazil Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million) 80

11.1.8.3       Brazil Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million) 81

11.1.8.4       Brazil Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million) 82

11.1.8.5       Brazil Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million) 83

11.1.9     Argentina: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 84

11.1.9.1       Argentina: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million) 84

11.1.9.2       Argentina Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million) 85

11.1.9.3       Argentina Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million) 86

11.1.9.4       Argentina Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million) 87

11.1.9.5       Argentina Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million) 87

12.        Impact Of COVID-19 Pandemic On Central and South America Cancer Vaccines Market 89

12.1      Central and South America: Impact Assessment of COVID-19 Pandemic. 89

13.        Cancer Vaccines Market – Industry Landscape. 91

13.1      Overview.. 91

13.2      Growth Strategies Done by the Companies in the Market, (%) 92

13.3      Organic Developments. 93

13.3.1     Overview.. 93

13.4      Inorganic Developments. 94

13.4.1     Overview.. 94

14.        Company Profiles. 96

14.1      CSL Limited. 96

14.1.1     Key Facts. 96

14.1.2     Business Description. 96

14.1.3       Products and Services. 97

14.1.4     Financial Overview.. 98

14.1.5     SWOT Analysis. 100

14.1.6       Key Developments. 101

14.2      ADURO BIOTECH INC. 102

14.2.1     Key Facts. 102

14.2.2     Business Description. 102

14.2.3       Products and Services. 103

14.2.4     Financial Overview.. 104

14.2.5     SWOT Analysis. 105

14.2.6     Key Developments. 106

14.3      Astellas Pharma Inc. 107

14.3.1     Key Facts. 107

14.3.2     Business Description. 107

14.3.3     Products and Services. 108

14.3.4     Financial Overview.. 109

14.3.5     SWOT Analysis. 111

14.3.6     Key Developments. 112

14.4      Bristol-Myers Squibb Company. 113

14.4.1     Key Facts. 113

14.4.2     Business Description. 113

14.4.3     Products and Services. 114

14.4.4     Financial Overview.. 115

14.4.5     SWOT Analysis. 118

14.4.6     Key Developments. 119

14.5      GlaxoSmithKline plc. 120

14.5.1     Key Facts. 120

14.5.2     Business Description. 120

14.5.3     Products and Services. 122

14.5.4     Financial Overview.. 123

14.5.5     SWOT Analysis. 127

14.5.6     Key Developments. 128

14.6      Dendreon. 129

14.6.1     Key Facts. 129

14.6.2     Business Description. 129

14.6.3     Products and Services. 129

14.6.4     Financial Overview.. 129

14.6.5     SWOT Analysis. 130

14.6.6     Key Developments. 131

14.7      AstraZeneca. 132

14.7.1     Key Facts. 132

14.7.2     Business Description. 132

14.7.3     Products and Services. 133

14.7.4     Financial Overview.. 134

14.7.5     SWOT Analysis. 136

14.7.6     Key Developments. 137

14.8      Merck & Co., Inc. 138

14.8.1     Key Facts. 138

14.8.2     Business Description. 138

14.8.3     Products and Services. 139

14.8.4     Financial Overview.. 140

14.8.5     SWOT Analysis. 144

14.8.6     Key Developments. 144

14.9      Sanofi (Sanofi Pasteur) 146

14.9.1     Key Facts. 146

14.9.2     Business Description. 146

14.9.3     Products and Services. 147

14.9.4     Financial Overview.. 148

14.9.5     SWOT Analysis. 152

14.9.6     Key Developments. 152

14.10   OSE Immunotherapeutics. 154

14.10.1  Key Facts. 154

14.10.2  Business Description. 154

14.10.3  Products and Services. 155

14.10.4  Financial Overview.. 156

14.10.5  SWOT Analysis. 158

14.10.6  Key Developments. 158

15.        Appendix. 160

15.1      Glossary of Terms. 160


LIST OF TABLES

Table 1. South and Central America Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 2. South and Central America Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027  (USD Million)
Table 3. South and Central America Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027  (USD Million)
Table 4. South and Central America Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 5. Brazil Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Brazil Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 7. Brazil Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 8. Brazil Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 9. Argentina Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 10. Argentina Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 11. Argentina Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 12. Argentina Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Organic Developments Done By Companies
Table 14. Inorganic Developments Done By Companies
Table 15. Glossary of Terms, Cancer Vaccines Market

LIST OF FIGURES

Figure 1. Cancer Vaccines Market Segmentation
Figure 2. Cancer Vaccines Segmentation – By Region
Figure 3. Central and South America Cancer Vaccines Market Overview
Figure 4. In Recombinant Cancer Vaccines Segment Held Largest Share of Cancer Vaccines Market in 2019
Figure 5. Cancer Vaccines Market in US to Show Remarkable Growth During Forecast Period
Figure 7. Central and South America PEST Analysis
Figure 8. Cancer Statistics, 2020
Figure 9. Cancer Vaccines Market Impact Analysis of Driver and Restraints
Figure 10. Central and South America Cancer Vaccines Market – Revenue Forecast And Analysis – 2019- 2027
Figure 11. Cancer Vaccines market Share, by Technology, 2019 and 2027 (%)
Figure 12. Dendritic Cells Cancer Vaccines : Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Antigen Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Whole Cell Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Viral Vector Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)
Figure 18. Preventive Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Therapeutic Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)
Figure 21. Cervical Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Prostate Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Other Indications: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)
Figure 25. Pediatrics: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Adults: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Central and South America: Cancer Vaccines Market, by Key Country – Revenue (2019) (USD Million)
Figure 28. Central and South America Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 29. Central and South America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)
Figure 30. Brazil: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. UK: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. France: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. Spain: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. Italy: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in Central and South America Country Markets
Figure 36. Growth Strategies Done by the Companies in the Market, (%)

 

 

The List of Companies - South and Central America Cancer Vaccines Market

  1. AstraZeneca
  2. GlaxoSmithKline plc.
  3. Aduro Biotech Inc
  4. Pfizer Inc.
  5. Sanofi
  6. Bristol-Myers Squibb
  7. Moderna, Inc.
  8. OncBioMune Pharmaceuticals Inc.
  9. MaxiVAX
  10. Nouscom
  • To understand the South & Central America cancer vaccines market landscape and identify market segments that are most likely to guarantee a strong return.
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for the South & Central America cancer vaccines market.
  • Efficiently plan M&A and partnership dealsin the South & Central America cancer vaccines market by identifying market segments with the most promising probable sales.
  • Helps to takeknowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the South & Central Americacancer vaccines market.
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in the region
TIPRE00015134
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing